MB

Martin Brenner

CEO & CSO

iBio, Inc.

San Diego, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
iBio, Inc.
Industry
research
Employees
55.0
Seniority
C suite
Annual Revenue
375000.0

Technologies

Outlook Microsoft Office 365 Amazon AWS Citrix Hubspot Mobile Friendly Apache BugHerd Google Analytics Google Tag Manager reCAPTCHA WordPress.org Linkedin Marketing Solutions Hotjar AI Remote IoT

Keywords

monoclonal antibodies biopharmaceuticals drug discovery artificial intelligence drug development immunooncology health care biotechnology research biotechnology ai-driven therapeutics cardiometabolic diseases obesity treatments precision medicine antibody discovery epitope engineering human antibody library machine learning therapeutic pipeline clinical development bi-specific antibodies weight loss muscle preservation safety profile stable antibody optimization anti-myostatin antibody medication adherence immune-mediated toxicities convenient dosing side effects reduction ai drug discovery platform collaborative partnerships advanced biopharmaceuticals immuno-oncology targeted therapies clinical candidates metabolic syndrome treatment fda approvals clinical trials biopharma innovation drug development efficiency healthcare collaboration patient-centric solutions biologics antibody masking technology precision targeting ai-powered optimization therapeutic candidates accelerated drug development precision antibodies obesity management on-target therapeutics high-value pipeline assets solid tumor targeting novel therapeutic agents next-generation medicine antibody therapeutics ai-driven drug discovery fastpharming technology cancer therapies metabolic health regulatory t-cell depletion solid tumors advanced manufacturing biopharmaceutical development scalable production environmental sustainability integrated solutions patient outcomes innovative treatments healthcare sector pharmaceutical preparations research institutions collaborations astralbio partnership cost-effective manufacturing rapid development timelines unmet medical needs advanced computational biology epitope steering technology t-cell engagement conditionally activated antibodies information technology & services health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans